Clinical Trial Update: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Status update shows a Phase 2 randomized trial comparing docetaxel/carboplatin versus docetaxel/Caelyx in pretreated ovarian cancer patients has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Caelyx (liposomal doxorubicin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED